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PURPOSE. To systematically assess the changes in retinal mor-
phology during the healing of retinal photocoagulation lesions
of various clinical grades.
METHODS. Rabbits were irradiated with a 532-nm Nd:YAG laser
with a beam diameter of 330 m at the retinal surface, a power
of 175 mW, and pulse durations between 5 and 100 ms. Retinal
lesions were clinically graded 1 minute after placement as
invisible, barely visible, light, moderate, intense, very intense,
and rupture and were assessed histologically at six time points
from 1 hour to 4 months.
RESULTS. At all pulse durations, the width of the retinal lesions
decreased over time. At clinical grades of light and more severe
(pulse durations, 10–100 ms), retinal scarring stabilized at 1
month at approximately 35% of the initial lesion diameter.
Lesions clinically categorized as barely visible and invisible
(pulse durations of 7 and 5 ms) exhibited coagulation of the
photoreceptor layer but did not result in permanent scarring.
In these lesions, photoreceptors completely filled in the dam-
aged areas by 4 months.
CONCLUSIONS. The decreasing width of the retinal damage zone
suggests that photoreceptors migrating from unaffected areas
fill in the gap in the photoreceptor layer. Laser photocoagula-
tion parameters can be specified to avoid not only the inner
retinal damage, but also permanent disorganization and scar-
ring in the photoreceptor layer. These data may facilitate stud-
ies to determine those aspects of laser treatment necessary for
beneficial clinical response and those that result in extraneous
retinal damage. (Invest Ophthalmol Vis Sci. 2008;49:
5540–5545) DOI:10.1167/iovs.08-1928
Retinal laser photocoagulation was first described 45 yearsago1 and remains the standard of care for many retinal
diseases. Panretinal photocoagulation (PRP) for proliferative
diabetic retinopathy involves the purposeful destruction of a
significant fraction of the photoreceptors, as well as other
more superficial retinal layers.2 Several mechanisms have been
suggested to underlie the efficacy of PRP and other laser treat-
ments, including improved retinal oxygenation, reduction in
metabolic activity, inhibition of angiogenic stimulators, in-
creased production of angioinhibitory factors, and oxidative
stress.3–6 Side effects of PRP treatment include permanent
retinal scarring, resulting in scotomas and decreased periph-
eral, color, and night vision.7 It remains largely unknown how
these putative benefits of PRP or its many deleterious side
effects7 relate to parameters of laser treatment and subsequent
retinal healing. Several investigators have presented evidence
that light PRP (minimum-intensity photocoagulation)8,9 or
even subvisible treatment (micropulse photocoagulation)10,11
has an efficacy equivalent to that of conventional PRP in caus-
ing regression of high-risk proliferative diabetic retinopathy
and is associated with fewer complications and fewer treat-
ment sessions. In a recent report, at 12 months, light PRP was
equivalent to classic PRP in reduction or elimination of diabetic
macular edema, visual improvement, change in contrast sensi-
tivity, and decreased foveal retinal thickness on OCT.8 Both of
these approaches claim to offer the therapeutic benefit of
conventional therapy without many of its side effects.12 How-
ever, many physicians remain skeptical about these claims, and
a prospective randomized clinical trial is needed to provide
convincing evidence one way or the other.
Recent studies have begun to explore the evolution of
laser-induced retinal lesions over time.13 Retinal lesions in rats
were shown to stabilize by 60 days.14 Immunohistochemical
studies of the laser lesions in mice 4 weeks after treatment have
shown that the healing processes are driven by cells and
vessels that are retinal in origin.14,15 It has also been found that
the lesion size in rodents decreases over time due to migration
of photoreceptors from the untreated surrounding areas, filling
in the damaged outer retina.16 Healthy adjacent photorecep-
tors have been shown to repopulate regions of photoreceptor
damage in a process associated with actin.17 The lesions of 200
m showed resolution of damage in the photoreceptor layer,
whereas 800-m lesions did not.16 This observation suggests
that photoreceptor migration may have a finite limit.16 Postin-
jury proliferation and migration of neurons have also been
recently described in several other neuronal systems.18–21 Al-
though rodent studies have provided important insight into the
dynamics of retinal healing and remodeling, the lack of retinal
scarring in rodents makes it a suboptimal model for retinal
photocoagulation lesions in humans.
In this study we provide a systematic histologic analysis of
the effects of retinal photocoagulation and describe the dynam-
ics of healing and reorganization of retinal lesions of various
clinical grades in rabbits. This study of laser-induced retinal
lesions was facilitated by the use of a recently developed
semiautomated retinal photocoagulation system (PASCAL; Op-
tiMedica Inc., Santa Clara, CA).22 This delivery system allows
for creating well-aligned arrays of retinal lesions with variable
durations of laser exposure and power. The effects of pulse
duration and laser power on the initial size and character of
retinal photocoagulation lesions in rabbits have been de-
scribed.22,23 The purpose of the present study was to deter-
mine the treatment parameters for retinal photocoagulation
that allow avoiding not only inner retinal damage, but also
permanent disorganization and scarring in the photoreceptor
layer. This study is a step toward determination of those as-
pects of laser treatment necessary for clinical response and
those that result in extraneous retinal damage.
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METHODS
Pattern Scanning Photocoagulation
This laser system (PASCAL; OptiMedica Inc.) provides 532 nm optical
radiation from a diode-pumped, continuous wave, frequency-doubled
Nd:YAG laser coupled to a multimode step index optical fiber. The exit
surface of the fiber is telecentrically imaged through the scanning
system onto the retina with variable magnification, thus providing a
variety of spot sizes with nominally top-hat intensity profiles. At the
aerial image plane of the slit lamp microscope the laser spots measure
500 m in diameter, with the laser intensity transition from 10% to 90%
occurring over 6 m. Variation of the beam intensity within the top-hat
area does not exceed 7%. A touch-screen graphic user interface is
used to control laser parameters including the spot size, laser power,
pulse duration, and pattern geometry. Once the treatment parameters
are appropriately selected, a foot pedal is used to activate the laser.
Retinal Laser Application
Eighteen Dutch Belted rabbits (weight, 2–3 kg) were used in accor-
dance with the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research, after approval from the Stanford University Ani-
mal Institutional Review Board. The rabbits were anesthetized with
ketamine hydrochloride (35 mg/kg, IM), xylazine (5 mg/kg, IM), and
glycopyrrolate (0.01 mg/kg, IM), administered 15 minutes before the
procedure. Pupillary dilation was achieved by 1 drop each of 1%
tropicamide and 2.5% phenylephrine hydrochloride. Topical tetracaine
0.5% was instilled in the treated eye before treatment. Only one eye of
each rabbit was treated, unless the rabbit was to be killed immediately.
A standard retinal laser contact lens (Mainster model OMRA-S;
Ocular Instruments, Bellevue, WA) was used to focus the laser on the
rabbit fundus. Taking into account the combined magnifications of the
contact lens and rabbit eye of 0.66,24 the aerial image of 500 m
corresponded to a retinal spot size of 330 m. Using modified scanning
software, columns consisting of six exposures with pulse durations of
5, 7, 10, 15, 20, 50, and 100 ms were applied. Five identical columns
were applied in each eye to broaden the statistical base of the study.
Laser power was maintained at 175 mW for all lesions. Placement of
larger marker burns adjacent to the patterned lesions facilitated later
histologic localization of the barely visible and invisible lesions.
The clinical appearance of the laser lesions were graded by a single
masked observer within 1 minute after the treatment according to the
following scale: invisible, barely visible, light, moderate, intense, very
intense, and rupture. The barely visible lesions were defined as a faint
lightening of the fundus pigmentation. Light burns exhibited further
blanching but without frank whitening. Moderate lesions exhibited
definite retinal whitening without adjacent edema, and intense burns
displayed central whitening and a halo of translucent edema. Very
intense lesions had a more marked and complete central retinal whit-
ening and a larger ring of edema. A rupture was assumed to have
occurred if small bubbles with or without hemorrhage appeared at the
lesion site.
Retinal Histology
Rabbits (three in each group) were killed 1 hour, 1 day, 1 week, 1
month, 2 months, or 4 months after treatment with a lethal dose of an
IV barbiturate (Beuthanasia; Schering-Plough Animal Health Corp.,
Kenilworth, NJ) in an ear vein. The eyes were enucleated and fixed in
1.25% glutaraldehyde/1% paraformaldehyde in cacodylate buffer at pH
7.2 overnight at room temperature. The eyes were then postfixed in
osmium tetroxide, dehydrated with a graded series of ethanol, pro-
cessed with propylene oxide, embedded in an epoxy resin, and sec-
tioned into 1 m-thick sections. Samples were stained with toluidine
blue and examined by light microscopy.25
Serial sections of the retina were examined, and four burns from
two different animals were analyzed for each of the six time points and
seven pulse durations (168 in total). By visually scanning the serial
sections, three widest lesions corresponding to each burn were mea-
sured using a microscope measuring scale. The lesion size was mea-
sured as the furthest extent of damage at the RPE-photoreceptor
junction. These three measurements for each of the four burns were
averaged, and representative lesions for each time point were photo-
graphed. The mean and SD of these 12 numbers were calculated
(Excel; Microsoft, Redmond, WA). The total size of the measurements
database was 504 numbers (168  3).
Fluorescein Angiography
For fluorescein angiography (FA), 0.3 mL of contrast (Fluorescite 10%;
(Alcon Laboratories, Hünenberg, Switzerland) was slowly (10 seconds)
injected into the marginal ear vein as described elsewhere.26 Fundus
photographs were taken with a fundus camera (TRC 50 [Topcon,
Tokyo, Japan], using a Kodak Megaplus Camera, Model 1.4 [Eastman
Kodak, Rochester, NY], operated by Winstation imaging software
[Ophthalmic Imaging Systems, Inc, Sacramento, CA]), starting a few
seconds after the injection, and every 20 seconds for up to 5 minutes.
Fluorescein angiography was performed 1 hour and 1, 3, and 7 days
after the placement of lesions with all clinical grades: very intense,
intense, moderate, light, barely visible, and invisible.
RESULTS
Histology
Intense Lesions. As shown in Figure 1, at 1 hour after
treatment, intense lesions were sharply demarcated and en-
compassed all retinal layers, as well as the retinal pigment
epithelium (RPE) and choroid. Retinal edema was present, and
the normal laminar architecture of the retina was disorganized
by displacement of the outer retina.
At 1 day, edema was nearly resolved in the inner and outer
retina. The inner and outer nuclear layers (INL and ONL) were
sparse and contained pyknotic nuclei. Photoreceptor inner
segments appeared shortened, and the outer segments ap-
peared in disarray. Even though RPE cells were clearly affected,
the RPE pigmentation appeared largely normal. Hyaline (pale
FIGURE 1. Figures 1 through 5 show progression of the lesions pro-
duced with a retinal beam size of 330 m in diameter, with laser power
of 175 mW. Sections were stained with toluidine blue. Photographs
were taken via 20 microscope objective, except for a 1-hour lesion,
which was photographed using 10 magnification due to its large size
(and has its own scale bar). Yellow bar: the extent of damage at the
RPE-photoreceptor junction. GCL, ganglion cell layer; INL, inner nu-
clear layer; ONL, outer nuclear layer; RPE, retinal pigment epithelium;
CHO, choroid. Shown in this figure is a representative intense lesion
produced by 100-ms pulse. The lesion encompassed all retinal layers.
Pigmented cells invaded the full thickness of the retina from 1 week to
2 months. At 4 months, a scar occupied the 36% of the initial lesion.
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blue) vacuoles were present between the basal RPE and
Bruch’s membrane. There appeared to be a loss of choroidal
structures accompanied in part by vascular engorgement and
exudation. The lateral extent of the damage zone became less
clear because of scattered, enlarged INL and ONL cells at the
lesion borders.
At 1 week, intense lesions had contracted to 54% of their
initial diameter (Table 1). INL cells remain enlarged, but extra-
cellular edema was now absent. Pigmented cells invaded the
full thickness of the retina. Retinal architecture was now diffi-
cult to discern because of partial loss of cells and their replace-
ment with gliotic tissue in all retinal layers. The RPE was
discontinuous, with large pigmented clumps interspersed with
depigmented areas. Multilayered hypopigmented cells were
present on an intact Bruch’s membrane. Vascular caliber had
normalized in larger choroidal vessels, but remained decreased
within the choriocapillaris, which was less dense. Choroidal
thickness had returned to normal.
At 1 month, edema was absent and the lateral/horizontal
width of the lesion was 40% of its initial size. Gliosis and
pigmented cells are present in all retinal layers, and there was
some central thinning. Hypertrophied and hyperpigmented
RPE was present.
At 2 months, the lesions further contracted to 37% of the
original lesion diameter, and otherwise appeared similar to
lesions at 1 month.
At four months, the lesion diameter was still approximately
36% of the original lesion and similar in appearance as at 2
months, with the exception that intraretinal pigmented cells
had disappeared and the lesion largely consisted of hypocellu-
lar matrix.
Light and Moderate Lesions. One hour after treatment
the light-to-moderate lesion exhibits strong edema in the inner
retina, damaged inner and outer nuclear layers, and large vacu-
oles in the inner segment layer (Figs. 2, 3). Choroidal changes
are less pronounced than in the intense lesion.
At day 1, retinal edema had decreased considerably. Inner
and outer segments of photoreceptors were strongly reduced,
and nuclei in the ONL were small and pyknotic within the
boundaries of the lesion. The INL nuclei appeared more round
and enlarged, compared with the surrounding untreated retina.
The central defect in ONL and INL of intense lesions was
absent.
At 1 week, there was no significant choroidal involvement.
ONL and most of the INL were replaced by gliotic tissue and
were invaded by pigmented cells. Continuous hypopigmented
RPE layer can be clearly seen in Figure 3.
FIGURE 2. Light-moderate lesions (20-ms pulse duration) at initial
stage (1 hour) involved strong edema in the inner retina above the
destroyed layer of photoreceptors. Edema largely subsided by 1 day,
and damaged photoreceptors were replaced with hypertrophied glia
by 1 week. The scar was largely stabilized after 1 month and covered
40% of the initial lesion size at 4 months.
TABLE 1. Relative Width of the Retinal Lesions of Various Grades over Time, as Measured at the
RPE-Photoreceptor Junction
Clinical Grade Pulse Duration (ms)
Days after Treatment
0 1 7 30 60 120
Intense 100 100 76 54 40 37 36
Moderate 50 100 91 42 39 37
Light-moderate 20 100 89 87 42 44 40
Light 15 100 92 82 35 38 38
Light 10 100 71 67 50 33 50
Barely visible 7 100 89 69 10 10 6
Invisible 5 100 72 34 15 1 0
Data are expressed as percentage of the initial lesion size. For each pulse duration, the width for all
time points was normalized to the size of the retinal lesion at 1 hour. Intense to light lesions stabilized at
approximately 40% of the initial lesion size at 2 months. Barely visible and invisible lesions continued to
heal, so that there was no visible defect at the RPE–photoreceptor junction at 4 months.
FIGURE 3. In the light lesions (15-ms pulse duration), initial damage
was localized to the photoreceptors. The RPE layer was restored by 1
week, although the cells appeared hypopigmented. The width of the
gliotic scar in the outer retina stabilized by 1 month at approximately
40% of its original size.
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At 1 month, the lesion had contracted asymmetrically and
appeared larger toward the inner retina and smaller at the RPE.
The INL was thickened, and its cells were enlarged in the
center of the lesion. Photoreceptors filled the peripheral part
of the lesion, leaving a remaining damage zone of 40% of the
original width. The RPE was hyperpigmented in the lesion
periphery with zones of hypopigmentation and pigmented
cellular aggregates more centrally.
At 2 months, the cellular accumulation in the center of the
lesion remained displaced toward the RPE, patchy gliosis filled
in the cellular gaps in the photoreceptor layer, and a decreased
number of hyperpigmented cells remained in the retina. RPE
pigmentation appeared more continuous, with some small
clumps of pigmented cells remaining. The width of the lesion
continued to be 40% of its original size.
At 4 months, the lesion maintained its size at 40%, although
the INL regained its normal structure at the periphery. The
central portion of the INL remained displaced toward the RPE,
and the gap in the photoreceptor layer remained filled in with
gliosis and displaced INL cells.
Barely Visible and Invisible Lesions. As shown in Figure
4, the barely visible lesions differed both quantitatively and
qualitatively from the more intense lesions. Initial lesion diam-
eters were smaller than those of lesions created with longer
pulse durations (see Fig. 6).
At 1 hour, the inner retina appeared largely unaffected,
whereas the ONL was hyperchromatic. RPE seemed collapsed,
but its pigmentation remained unchanged. Outer segments of
photoreceptors were disorganized, and the nuclei were py-
knotic.
At 1 day, there was slight edema in the inner retina, but
both INL and GCL seemed to be only minimally affected. Inner
segments of photoreceptors were shortened, the outer seg-
ments depigmented, and the ONL displaced toward the RPE.
The RPE had a hypochromatic cytoplasm.
At 1 week, the INL was slightly expanded, and missing
photoreceptors were probably replaced by glial elements. Ret-
inal edema was mild and localized primarily to the outer retina.
The RPE layer was restored, but seemed hypopigmented in the
center of the lesion. The choroid appeared normal. The lesion
contracted to 69% of its original size.
At 1 month, the lesion had contracted to 10% of its initial
diameter. Histologic changes were localized to the outer retina
and consisted of a thinned ONL and disorganized photorecep-
tors in the center of the lesion. Gliosis and downward displace-
ment of the INL were notably absent. Intraretinal pigmented
cells, present in more severe lesion grades, were absent as
well.
At 2 months, the lesion was similar to that at 1 month. A few
hyperpigmented RPE cells were evident only in the center of
the lesion.
At 4 months, the lesion was distinguished from adjacent
normal retina only by a few-cells-wide area of decreased den-
sity within the ONL with occasional adjacent vacuoles in the
inner segments, and slight elevation. Mild and variable hyper-
pigmentation at the RPE level persisted in some lesions. Pho-
toreceptor morphology within lesions was otherwise indistin-
guishable from that in untreated retina.
Histology of ophthalmoscopically invisible lesions (5-ms
exposures) revealed even more localized damage to photore-
ceptors and RPE, with excellent preservation of the other
retinal layers (Fig. 5). Healing of the lesion followed steps
similar to those of the barely visible lesion, with even more
FIGURE 5. Invisible lesion produced with 5-ms pulse duration exhib-
ited laser damage localized to photoreceptors and RPE. Damaged
photoreceptors were replaced within a few weeks, with normal retinal
morphology completely restored by 4 months.
FIGURE 6. The width of the retinal lesions of various grades over time,
as measured at the RPE–photoreceptor junction. All lesions decreased
in size, and more intense lesions are wider initially. Moderate and
intense burns stabilized at 150 m and light to light-moderate burns
stabilized at 100 m by 2 months, with minimal change in size at 4
months. Barely visible and invisible lesions continued to heal to com-
plete closure by 4 months. Error bars show the SD for each time point
of each of four burns measured per time point.
FIGURE 4. Barely visible lesions produced at 7-ms pulse duration ex-
hibited perfect localization of the retinal damage to photoreceptors.
Gliotic replacement of the damaged photoreceptors continued to con-
tract over time, showing an outer retina with almost continuous nor-
mal morphology at 4 months.
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complete resolution by the end of 4 months. In additional
experiments, pulse durations of 3 ms and shorter failed to
produce ophthalmoscopically visible burns. Retinal histology
appeared entirely normal within the treated region (data not
shown).
Changes in the lateral extent of the retinal lesions over time
were summarized in the plot shown in Figure 6. Table 1 shows
the relative lesion sizes over time, normalized on initial lesion
size at 1 hour.
Fluorescein Angiography
At 1 hour and 1 day after laser application, all clinical grades of
laser lesions (from invisible to very intense) exhibited hyper-
fluorescence with fluorescein angiography. At 3 days, light and
more intense lesions remained hyperfluorescent, whereas clin-
ically invisible and barely visible lesions were not evident on
angiography. By 7 days after laser application, none of the
lesions remained hyperfluorescent.
DISCUSSION
The present study provides a systematic assessment of histo-
logic changes over time in retinal photocoagulation lesions of
various clinical grades in rabbits. Use of the pattern delivery
system (PASCAL; OptiMedica Inc.) helped, with rapid and
well-aligned application of multiple lesions with variable pulse
durations. We achieved consistent clinical levels of lesion in-
tensities by varying pulse duration while maintaining constant
spot size and power settings. Since laser power, spot size, and
pulse duration affect the resulting lesion character in a differ-
ent fashion,23 our results may not be entirely generalizable to
lesions that differ in their clinical grade due to variations in
spot size and/or power settings. Since lesion size decreases
with decreasing pulse duration and laser power, more burns or
larger laser spot sizes are necessary to treat an equivalent
retinal area that may be essential to reach a similar clinical
efficacy.
For all clinical grades, the lateral extent of retinal damage
decreased over time, with the extent of reduction dependent
on the initial width and the severity of the lesion. Within 2
months the intense, moderate, and light lesions decreased in
width by a factor of 3, whereas the barely visible and invisible
lesions disappeared nearly entirely. Retinal gliosis appeared
only temporarily between 1 and 4 weeks in barely visible
lesions, whereas in more intense burns, it stabilized by 1
month, and persisted at 4 months. The end-stage histology of
the light, moderate, and intense burns is similar. Similar healing
rates have been observed during experimental RPE debride-
ment in rabbits.27 Resolution of fluorescein angiography hy-
perfluorescence by 1 week corroborates the anatomic demon-
stration that RPE continuity was restored by 1 week (see for
example, Fig. 3). For invisible and barely visible lesions, this
continuity occurred even faster—by 3 days.
Lateral photoreceptor migration to replace initial cell loss
has been suggested by previous studies in the rat retina.16
However, restoration of the photoreceptor layer in rats was
more rapid, reaching its maximum extent by 3 weeks, whereas
we found this process continuing in rabbits throughout the
4-month period of observation, particularly in the first 2
months. In addition, retinal lesions in rats exhibit less gliosis
than in rabbits. Observation of the photoreceptors migration in
both the merangiotic rabbit model and the holangiotic rat
model of retinal photocoagulation, indicate the likelihood of
similar phenomenon in humans. High-resolution OCT imaging
of the evolution of retinal lesions of various grades in patients
could provide such evidence.
Photoreceptor outer segments damaged during selective
RPE photocoagulation in rabbits have been shown to recover
by 4 weeks after laser irradiation after initial disc disorganiza-
tion and vacuolization.28 However, it is unlikely that, in our
case, photoreceptor restoration after retinal photocoagulation
was due to the recovery of damaged outer segments since
outer nuclear layer pyknosis at 1 day proceeded to large visible
lesions devoid of nuclei at 1 week.
Remaining unknown is the role of neuronal regeneration in
the restoration of the photoreceptor layer observed in our
study, either through differentiation of resident neuronal stem
cells at the ciliary margin29–36 or the transdifferentiation of
Müller glia.37
Regardless of the mechanism, restoration of retinal continu-
ity has clinically important implications. If the therapeutic
benefit of PRP involves reduction in the number of photore-
ceptors, it can be achieved more selectively using barely visible
or invisible lesions without the permanent scarring of more
intense lesions. Restoration of retinal continuity and absence of
scarring might reduce microscotomas typical of conventional
PRP and may also allow for retreatment.
In addition, such minimally traumatic therapy reduces the
level of pain and discomfort associated with PRP. Application
of the barely visible or invisible lesions is facilitated using
arrays that can incorporate higher intensity visible marker
burns at the corners (Pascal; OptiMedica Inc.). Such lesions
enable proper placement of successive applications of arrays.
Our results may also form the basis for a useful model of
retinal fibrosis. Fibrosis remains a major clinical problem in
ophthalmology and is the key factor causing irreversible blind-
ness in several diseases, including subretinal scarring in end-
stage macular degeneration. We have shown that several fea-
tures of retinal healing (e.g., cell death, edema, RPE invasion,
gliosis, and matrix deposition) can be predictably isolated or
combined within lesions by varying the parameters of laser
treatment. Our descriptions of these graded responses may
thus facilitate scientific investigation into discrete steps in
retinal wound healing and allow for the assessment of potential
therapies to prevent or resolve retinal fibrosis.
In summary, we have described the histopathology of reti-
nal photocoagulation lesions across a wide spectrum of clinical
grades and over an extended time course. These data may be
useful in further evaluations of mechanisms of retinal healing
and may form the basis for a rational approach to optimizing
parameters for clinical retinal laser therapy.
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